RNA interference for treating cancers caused by viral infection

Expert Opinion on Biological Therapy
Jo Milner

Abstract

The newly discovered phenomenon of RNA interference (RNAi) offers the dual facility of selective viral gene silencing coupled with ease of tailoring to meet genetic variation within the viral genome. Such promise identifies RNAi as an exciting new approach to treat viral-induced diseases, including viral-induced cancers (e.g. cervical carcinoma, hepatocellular carcinomas and haematopoietic and lymphoid malignancies). Cervical cancer is the second most common cancer in women worldwide and is caused by human papilloma virus (HPV). Silencing of HPV gene expression by RNAi induces apoptosis of cervical carcinoma cells in culture, and the effect is apparent within 3 days. The RNAi process is triggered by double-stranded RNA (dsRNA), and a single dose is sufficient to maintain RNAi for several days in vitro (cell culture) and in vivo (experimental animal models). Thus, the stage is set for the development of novel antiviral and anticancer therapies based upon selective gene silencing by RNA interference.

References

Nov 1, 1995·Nature Medicine·C A Stein
Apr 16, 1998·Trends in Biochemical Sciences·A D Branch
Aug 8, 1998·Genes & Development·N Dyson
May 4, 2000·Journal of the National Cancer Institute·H zur Hausen
Feb 7, 2001·Genes & Development·S M ElbashirT Tuschl
Jun 26, 2001·International Journal of Experimental Pathology·H R McMurrayD J McAnce
Oct 27, 2001·Science·M Lagos-QuintanaT Tuschl
Oct 27, 2001·Science·R C Lee, V Ambros
Mar 15, 2002·Current Opinion in Genetics & Development·György Hutvágner, Phillip D Zamore
Mar 23, 2002·Science·Thijn R BrummelkampReuven Agami
Jun 11, 2002·Methods : a Companion to Methods in Enzymology·Sayda M ElbashirThomas Tuschl
Jun 28, 2002·Nature·Jean-Marc JacqueMario Stevenson
Jul 5, 2002·Nature·Anton P McCaffreyMark A Kay
Jul 12, 2002·Nature·Gregory J Hannon
Jul 30, 2002·Nature Genetics·David L LewisHans Herweijer
Aug 24, 2002·Science·Thomas A VolpeRobert A Martienssen
Oct 9, 2002·Genes & Development·Andrea Cuconati, Eileen White
Nov 22, 2002·The New England Journal of Medicine·Laura A KoutskyUNKNOWN Proof of Principle Study Investigators
Dec 5, 2002·Trends in Immunology·Miguel Angel MartínezJosé A Esté
Dec 21, 2002·Science·Jennifer Couzin
Jan 1, 2003·Seminars in Cancer Biology·Martin Scheffner, Noel J Whitaker
Jan 9, 2003·Proceedings of the National Academy of Sciences of the United States of America·Glenn RandallCharles M Rice
Feb 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sharookh B KapadiaFrancis V Chisari
Feb 13, 2003·Nature Medicine·Erwei SongJudy Lieberman

❮ Previous
Next ❯

Citations

Dec 12, 2012·Advanced Drug Delivery Reviews·Christina KriegelMansoor Amiji
Apr 7, 2011·Archives of Pharmacal Research·Hun Soon Jung, Young Kee Shin
Aug 5, 2015·Journal of Clinical Medicine·Hun Soon JungYoung Kee Shin
May 5, 2007·Expert Opinion on Biological Therapy·John Doorbar, Heather Griffin
May 21, 2005·Journal of Surgical Oncology·Jannis KountourasDimitrios Chatzopoulos
Nov 19, 2003·Current Opinion in Infectious Diseases·Andrew GodfreyChris Boshoff
Apr 25, 2019·Journal of Biomedical Science·Sadhana M Gupta, Jayanti Mania-Pramanik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis